Patents for C12R 1 - Micro-organisms (92,025) |
---|
12/01/1998 | US5843714 DNA encoding a novel human proteolipid |
12/01/1998 | US5843711 Diphtheria toxin receptor-binding region |
12/01/1998 | US5843706 Vaccines against animal parasitic nematodes |
12/01/1998 | US5843687 Isolated, tyrosinase derived peptides and uses thereof |
12/01/1998 | US5843686 Methods of diagnosing metastatic cancer with MTS-1 protein |
12/01/1998 | US5843679 Method for selectively enhancing the production of factors A or B0 of antibiotic A 40926 complex |
12/01/1998 | US5843672 Allergenic proteins and peptides from dog dander and uses therefor |
12/01/1998 | US5843664 Method of selection of allelic exchange mutants |
12/01/1998 | US5843639 Hepatitis C virus epitopes |
12/01/1998 | US5843636 Hepatitis C virus epitopes |
12/01/1998 | US5843634 Genetically engineered enzymes and their conjugates for diagnostic assays |
12/01/1998 | US5843458 Recombinant human cytomegalovirus having a US2 deletion |
12/01/1998 | US5843448 Tumor rejection antigen precursor |
12/01/1998 | US5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
12/01/1998 | US5843437 A82846 antibiotics |
12/01/1998 | US5843426 Salmonella vaccines |
12/01/1998 | US5843405 Epstein-Barr virus peptides and antibodies against these peptides |
12/01/1998 | CA2022429C Methods and compositions for ameliorating the symptoms of sepsis |
11/30/1998 | CA2233577A1 Histidine kinase |
11/30/1998 | CA2233572A1 Histidine kinase |
11/30/1998 | CA2233547A1 Histidine kinase |
11/30/1998 | CA2233539A1 Histidine kinase |
11/30/1998 | CA2233411A1 Dextrane production |
11/29/1998 | CA2233561A1 Novel compounds |
11/26/1998 | WO1998053102A1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
11/26/1998 | WO1998053101A2 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases |
11/26/1998 | WO1998053078A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
11/26/1998 | WO1998053075A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
11/26/1998 | WO1998053052A1 Sialidases localized on plasma membranes and dna encoding the same |
11/26/1998 | WO1998053047A1 E. coli, salmonella or hafnia autoinducers |
11/26/1998 | WO1998052967A1 New echinocandide derivatives with antimicrobial activity |
11/26/1998 | WO1998046770A3 Stable biocatalysts for ester hydrolysis |
11/26/1998 | WO1998032847A3 Characterization of the yeast transcriptome |
11/26/1998 | WO1998030582A3 Secreted proteins and polynucleotides encoding them |
11/26/1998 | CA2783134A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis |
11/26/1998 | CA2291216A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
11/26/1998 | CA2290774A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis |
11/26/1998 | CA2232806A1 Purification of higher order transcription complexes from transgenic non-human animals |
11/25/1998 | EP0879893A1 Method of producing optically active 1,2,4-butanetriol |
11/25/1998 | EP0879889A2 A novel member of the IL-1 family, IL-1 delta |
11/25/1998 | EP0879294A1 Transduced human hematopoietic stem cells |
11/25/1998 | EP0879292A1 Anthranilate synthase gene and use thereof |
11/25/1998 | EP0879291A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
11/25/1998 | EP0879286A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
11/25/1998 | EP0879247A1 Glial cell line-derived neurotrophic factor receptors |
11/25/1998 | EP0661998B1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection with aids |
11/25/1998 | EP0602237B1 N-acetylglucosaminyltransferase v coding sequences |
11/25/1998 | CN1200150A Process for producing L-amino acids |
11/25/1998 | CN1200148A Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
11/25/1998 | CN1200146A Compounds and methods for diagnosis of tuberculosis |
11/25/1998 | CN1199776A Mutant prenyl diphosphate synthase |
11/24/1998 | US5840869 DNA encoding interleukin-4 receptors |
11/24/1998 | US5840868 Pesticidal proteins and strains |
11/24/1998 | US5840866 Human ubiquitin-conjugating enzyme |
11/24/1998 | US5840854 Monoclonal antibody BR110 and uses thereof |
11/24/1998 | US5840853 Parathyroid hormone receptor and DNA encoding same |
11/24/1998 | US5840847 Purified prostaglandin receptor FP |
11/24/1998 | US5840846 Fibronectin binding protein as well as its preparation |
11/24/1998 | US5840842 Receptor-type phosphotyrosine phosphatase-sigma |
11/24/1998 | US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
11/24/1998 | US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins |
11/24/1998 | US5840693 Vascular endothelial growth factor-B |
11/24/1998 | US5840687 Polypeptides for kinases |
11/24/1998 | US5840682 Peptide antagonists of neurotensin |
11/24/1998 | US5840566 Isolation of a gene encoding human thyrotropin beta subunit |
11/24/1998 | US5840565 Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
11/24/1998 | US5840554 β-Endotoxin expression in pseudomonas fluorescens |
11/24/1998 | US5840552 Using microorganisms or microbial enzyme system to produce stereospecific enantiomers; antiulcer agents |
11/24/1998 | US5840548 Culturing newly isolated strains of mycobacterium, agrobacterium, and rhizobacterium in medium containing aliphatic hydrocarbons until glycerides and phospholipids accumulate; recovering product from culture; cosmetics |
11/24/1998 | US5840545 Immunoglubulins |
11/24/1998 | US5840533 Tissue plasminogen activator |
11/24/1998 | US5840530 DNA encoding receptors for the beta-2 chain of human IL-12 |
11/24/1998 | US5840529 Mammalian pro-hormone convertase |
11/24/1998 | US5840528 Overexpression of carotenoids in protoplasts using recombinant dna comprising precursor gene with detectable marker operably linked to regulatory sequences; stability |
11/24/1998 | US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis |
11/24/1998 | US5840525 P185 receptor implicated in cellular growth |
11/24/1998 | US5840523 Using translation initiation region variant (including signal sequence of stii, ompa, phoe, lamb, mbp, and phoa) operably linked to unaltered amino acid coding region; variant has reduced translational strength but increased secretion |
11/24/1998 | US5840521 Teta and tetr genes induced by tetracycline and repressed in its absence, expressing a heterologous protein such as ricin a; no penicillin selection markers; highly stable vectors; product of selection only expressed in testing phase |
11/24/1998 | US5840518 Biosynthetic fusion protein comprising a polypeptide segment with a specified amino acid sequence giving signal, promoting transformed cell to secrete fusion protein |
11/24/1998 | US5840513 Antibodies directed to pagC peptides for the detection of salmonellae |
11/24/1998 | US5840505 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells |
11/24/1998 | US5840483 Method of maintaining a desired recombinant gene in a genetic population of cells |
11/24/1998 | US5840479 Synthetic human antibody-dna comprising an expression vector with inserted random sequences for the antibody hypervariable regions; clones able secrete specific antibodies or antigen-binding domain |
11/24/1998 | US5840315 Treating or preventing bovine mastitis |
11/24/1998 | US5840314 Production of streptococcal M protein |
11/24/1998 | US5840304 Amino acid sequences and codes for t-cells |
11/24/1998 | US5840299 Binding and treatment of multiple sclerosis |
11/24/1998 | US5840298 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
11/24/1998 | US5840297 Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process |
11/24/1998 | CA2077921C Bioprocess for preparing 7-adca |
11/24/1998 | CA1340140C Human gamma, delta t cell antigen receptor polypetides and nucleic acids |
11/19/1998 | WO1998051804A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
11/19/1998 | WO1998051803A1 Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same |
11/19/1998 | WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
11/19/1998 | WO1998051784A1 Modiified arginine deiminase |
11/19/1998 | WO1998051695A2 Novel polyketide derivatives and recombinant methods for making same |
11/19/1998 | WO1998051656A1 Method for the separation and purification of polyunsaturated fatty acid esters |
11/19/1998 | WO1998035014A3 Probiotic strains from lactobacillus salivarius and antimicrobial agents obtained therefrom |
11/19/1998 | WO1998034640A3 Synthetic hiv gag genes |
11/19/1998 | WO1998033896A3 Microorganisms with increased production of clavulanic acid |